The state of Texas currently has 3 active clinical trials seeking participants for Hepatitis C research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Recruiting
This is an open-label trial to evaluate safety and efficacy of treatment with BEM + RZR in subjects with chronic HCV infection.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
05/10/2024
Locations: Atea Study Site, San Antonio, Texas
Conditions: Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C, Hepatic Cirrhosis, HCV
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Recruiting
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/10/2023
Locations: Liver Center of Texas, Dallas, Texas +1 locations
Conditions: Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B, Hepatitis C, Diabetes, COPD
The Hepatitis C Transplant Collaborative
Recruiting
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2023
Locations: Baylor Scott & White Health Research Institute, Dallas, Texas
Conditions: Transplant; Failure, Heart, Hepatitis C